U54CA268069
Cooperative Agreement
Overview
Grant Description
Center for Multiparametric Imaging of Tumor Immune Microenvironments
This project proposes an integrated suite of microscopy and data analysis advances that would enable quantitative, mechanistic analysis of immune-microenvironment dynamics in poor prognosis solid tumors. While immunotherapies are showing remarkable clinical responses in some advanced cancers, to date, their impact on many solid tumors has been modest. This is due, in part, to solid tumor microenvironments limiting the effectiveness of natural immune responses and immunotherapies. Yet, our understanding of the physical and molecular mechanisms governing T cell infiltration, distribution, and function in native tumor microenvironments remains extremely limited.
As such, defining key T cell behaviors as a function of complex tumor microenvironments will identify design criteria that can be used to develop novel cell engineering strategies that optimize T cell-centric therapies for solid tumors. To this end, the research theme of the U54 Center for Multiparametric Imaging of Tumor Immune Microenvironments (C-MITIE) is to define physical and molecular barriers to effective anti-tumor immunity and immunotherapies through advancement and development of state-of-the-art live cell and tissue optical imaging platforms and quantitative analyses.
To achieve our goals, our framework brings together advanced optical imaging platforms, nano- and micro-fabrication, genome engineering, cancer immunology, and biophysical modeling. Thus, from this integrated effort, we seek to define mechanisms of immune suppression that guide the development of next-generation cell-based immunotherapies.
This project proposes an integrated suite of microscopy and data analysis advances that would enable quantitative, mechanistic analysis of immune-microenvironment dynamics in poor prognosis solid tumors. While immunotherapies are showing remarkable clinical responses in some advanced cancers, to date, their impact on many solid tumors has been modest. This is due, in part, to solid tumor microenvironments limiting the effectiveness of natural immune responses and immunotherapies. Yet, our understanding of the physical and molecular mechanisms governing T cell infiltration, distribution, and function in native tumor microenvironments remains extremely limited.
As such, defining key T cell behaviors as a function of complex tumor microenvironments will identify design criteria that can be used to develop novel cell engineering strategies that optimize T cell-centric therapies for solid tumors. To this end, the research theme of the U54 Center for Multiparametric Imaging of Tumor Immune Microenvironments (C-MITIE) is to define physical and molecular barriers to effective anti-tumor immunity and immunotherapies through advancement and development of state-of-the-art live cell and tissue optical imaging platforms and quantitative analyses.
To achieve our goals, our framework brings together advanced optical imaging platforms, nano- and micro-fabrication, genome engineering, cancer immunology, and biophysical modeling. Thus, from this integrated effort, we seek to define mechanisms of immune suppression that guide the development of next-generation cell-based immunotherapies.
Funding Goals
TO PROVIDE AN ORGANIZATIONAL FOCUS AND STIMULUS FOR THE HIGHEST QUALITY CANCER RESEARCH THAT EFFECTIVELY PROMOTES INTERDISCIPLINARY CANCER RESEARCH AIMED TOWARD THE ULTIMATE GOAL OF REDUCING CANCER INCIDENCE, MORTALITY AND MORBIDITY. THE CANCER CENTER SUPPORT GRANT (CCSG) PROVIDES THE RESOURCES AND INFRASTRUCTURE TO FACILITATE THE COORDINATION OF INTERDISCIPLINARY PROGRAMS ACROSS A BROAD SPECTRUM OF RESEARCH FROM BASIC LABORATORY RESEARCH TO CLINICAL INVESTIGATION TO POPULATION SCIENCE. THE CCSG SUPPORTS SALARIES FOR SCIENTIFIC LEADERSHIP OF THE CENTER, SHARED RESOURCES FOR FUNDED CENTER INVESTIGATORS, CERTAIN ADMINISTRATIVE COSTS, PLANNING AND EVALUATION, AND DEVELOPMENTAL FUNDS FOR NEW RECRUITMENTS AND FEASIBILITY STUDIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Minnesota
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 319% from $1,309,112 to $5,479,133.
Regents Of The University Of Minnesota was awarded
Center for Multiparametric Imaging of Tumor Immune Microenvironments
Cooperative Agreement U54CA268069
worth $5,479,133
from National Cancer Institute in December 2021 with work to be completed primarily in Minnesota United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.397 Cancer Centers Support Grants.
The Cooperative Agreement was awarded through grant opportunity Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 9/26/25
Period of Performance
12/9/21
Start Date
11/30/26
End Date
Funding Split
$5.5M
Federal Obligation
$0.0
Non-Federal Obligation
$5.5M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U54CA268069
Transaction History
Modifications to U54CA268069
Additional Detail
Award ID FAIN
U54CA268069
SAI Number
U54CA268069-1975887265
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
KABJZBBJ4B54
Awardee CAGE
0DH95
Performance District
MN-90
Senators
Amy Klobuchar
Tina Smith
Tina Smith
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,846,728 | 100% |
Modified: 9/26/25